What medications interact with Paxlovid (nirmatrelvir/ritonavir)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications That Interact with Paxlovid (Nirmatrelvir/Ritonavir)

Paxlovid has numerous significant drug interactions due to ritonavir's strong inhibition of CYP3A4 enzymes and effects on other metabolic pathways, requiring careful medication review before prescribing to avoid potentially life-threatening interactions. 1

Mechanism of Drug Interactions

Paxlovid causes drug interactions through several mechanisms:

  • Strong inhibition of CYP3A enzymes (primary mechanism)
  • Inhibition of CYP2D6
  • Inhibition of P-glycoprotein (P-gp) transporters
  • Inhibition of OATP1B1 transporters 1

These interactions can significantly increase plasma concentrations of co-administered medications, potentially leading to serious adverse effects.

Contraindicated Medications (Do Not Co-administer)

The following medications are absolutely contraindicated with Paxlovid:

  • Alpha-1 adrenoreceptor antagonists: Alfuzosin (risk of hypotension)
  • Antianginals: Ranolazine (risk of serious/life-threatening reactions)
  • Antiarrhythmics: Amiodarone, dronedarone, flecainide, propafenone, quinidine (risk of cardiac arrhythmias)
  • Anticancer drugs: Apalutamide, enzalutamide (reduce Paxlovid effectiveness)
  • Anticonvulsants: Carbamazepine, phenobarbital, phenytoin (reduce Paxlovid effectiveness)
  • Antimycobacterials: Rifampin, rifabutin, rifapentine (reduce Paxlovid effectiveness)
  • Herbal products: St. John's wort (reduces Paxlovid effectiveness)
  • Statins: Lovastatin, simvastatin (risk of myopathy including rhabdomyolysis) 1

Medications Requiring Dose Adjustment or Temporary Discontinuation

Anticoagulants

  • Rivaroxaban: Avoid concomitant use (increased bleeding risk)
  • Apixaban: Dose reduction required (refer to apixaban label)
  • Dabigatran: Dose reduction may be needed based on indication and renal function
  • Warfarin: Close INR monitoring required 1

Statins

  • Atorvastatin: Reduce dose or temporarily discontinue
  • Rosuvastatin: Reduce dose (not recommended at high doses) 2

Immunosuppressants

  • Tacrolimus: Requires significant dose reduction and therapeutic drug monitoring
  • Cyclosporine: Requires dose reduction and monitoring 3

Antipsychotics

  • Quetiapine: Reduce dose or temporarily discontinue
  • Clozapine: Requires careful monitoring 3

Calcium Channel Blockers

  • Amlodipine, diltiazem, felodipine, nifedipine, verapamil: Require dose reduction 3

Monitoring Recommendations

  1. Before prescribing Paxlovid:

    • Complete medication reconciliation including all prescription, OTC, and herbal products
    • Identify potential interactions using drug interaction databases
    • Determine if medications can be safely paused, dose-adjusted, or require alternative COVID-19 treatment
  2. During Paxlovid treatment:

    • Monitor for signs of toxicity from increased drug levels
    • For medications that cannot be paused but require dose adjustment, implement appropriate monitoring
    • Be particularly vigilant with narrow therapeutic index drugs
  3. After completing Paxlovid:

    • Resume normal medication dosing 2-3 days after completing Paxlovid course
    • Ritonavir's enzyme inhibition effects may persist for 3-5 days 4

Common Pitfalls to Avoid

  1. Failing to recognize "hidden" ritonavir: Remember that Paxlovid contains ritonavir, which has extensive drug interaction potential even at the low doses used

  2. Overlooking non-prescription medications: Many OTC medications and supplements can interact with Paxlovid

  3. Assuming a 5-day course is "too short" to cause problems: Even short-term Paxlovid can cause significant interactions

  4. Not considering alternatives: For patients on multiple interacting medications, alternative COVID-19 treatments may be safer

  5. Inadequate monitoring: Some interactions may require laboratory monitoring or close clinical follow-up during and after treatment 5

Algorithm for Managing Paxlovid Drug Interactions

  1. Identify all patient medications (prescription, OTC, supplements)
  2. Check each medication against Paxlovid interaction database
  3. Categorize interactions:
    • Contraindicated (do not use Paxlovid)
    • Requires dose adjustment (implement specific adjustments)
    • Requires temporary discontinuation (hold medication)
    • No significant interaction (can continue as prescribed)
  4. If contraindicated medications cannot be paused, consider alternative COVID-19 treatments
  5. Document all medication changes and provide clear instructions to the patient

Remember that this is not a comprehensive list of all possible interactions. Always consult current drug interaction databases and product labeling for the most up-to-date information when prescribing Paxlovid.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.